当前位置:
X-MOL 学术
›
Leuk. Res.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Venetoclax in combination with low dose Cytarabine and Actinomycin D for primary refractory acute myeloid leukemia patients failing intensive chemotherapy.
Leukemia Research ( IF 2.7 ) Pub Date : 2021-08-21 , DOI: 10.1016/j.leukres.2021.106692 Justinas Daraskevicius 1 , Veronika Everatt 1 , Vilmante Vaitekenaite 2 , Ugne Ringeleviciute 2 , Kazimieras Maneikis 2 , Andrius Zucenka 3
中文翻译:
Venetoclax 与低剂量阿糖胞苷和放线菌素 D 联合用于强化化疗失败的原发性难治性急性髓细胞白血病患者。
更新日期:2021-08-21
Leukemia Research ( IF 2.7 ) Pub Date : 2021-08-21 , DOI: 10.1016/j.leukres.2021.106692 Justinas Daraskevicius 1 , Veronika Everatt 1 , Vilmante Vaitekenaite 2 , Ugne Ringeleviciute 2 , Kazimieras Maneikis 2 , Andrius Zucenka 3
Affiliation
中文翻译:
Venetoclax 与低剂量阿糖胞苷和放线菌素 D 联合用于强化化疗失败的原发性难治性急性髓细胞白血病患者。